Immunohistochemistry results further supported our biochemical findings, showing reduced levels (~50%) of phosphorylated tau at S202/T205 in the brains of 3xTg-AD mice overexpressing NCLX (Fig. 3o, q). Here, MAPT is linked to Alzheimer disease.